L-Asparaginase entrapped in liposomes: Preparation and properties  by Fishman, Yolanta & Citri, Nathan
Volume 60, number 1 FEBS LETTERS December 1975 
L -ASPARAGINASE ENTRAPPED IN LIPOSOMES: PREPARATION AND PROPERTIES  
Yolanta FISHMAN and Nathan CITRI 
The Hebrew University-Hadassah Medical School, Jerusalem, Israel 
Received 17 September 1975 
1. Introduction 
L-Asparaginase has been used with remarkable 
success in the treatment of certain forms of leukemia 
[1,2]. However, a major drawback in its continued 
clinical application has been the frequently observed 
occurrence of hypersensitive r actions to the enzyme 
as a foreign protein [3,4]. 
In principle it should be possible to prevent or at 
least minimize the immunogenic effect of repeated 
administration of the enzyme by entrapping it within 
non-antigenic particles. The packaging of L-asparagi- 
nase in microcapsules which are immunologically inert 
has been described before [5,6]. However, the objec- 
tion has been raised that such microcapsules contain 
undegradable material which will accumulate in the 
body. The alternative approach of using liposomes 
[7] as inert vehicles [8] for L-asparaginase is outlined 
in this communication. We describe the preparation 
and some of the properties of asparaginase-carrying 
liposomes. Of particular interest is the observation 
that in such liposomes the antigenic determinants of
L-asparaginase are completely masked. The evaluation 
of the asparagine-liposomes in vivo is now in progress. 
2. Materials and methods 
L-Asparaginase from E. coli (EC 3.5.1.1, L-aspara- 
gine amidohydrolase) was a gift from Merck, Sharp 
and Dohme. Egg phosphatidylcholine was donated by 
Dr S. Gatt of the Department of Biochemistry, Medical 
School, Jerusalem. It was prepared in his laboratory 
as by Pangborn [9]. Dicetyl phosphate was purchased 
from Sigma Chemical Company, cholesterol and L- 
asparagine from Nutritional Biochemical Corporation. 
i Trypsin was obtained from Worthington Biochemical 
Corporation. 
2.1. Preparation of liposomes 
Liposomes were prepared as by Gregoriadis et al. 
[7] with slight modifications. Egg phosphatidylcholine 
(40/lmol), cholesterol (8/amol) and dicetyl 
phosphate (4/amol) were dissolved in 2 ml of chloro- 
form in a 50 ml round-bottomed flask. The chloroform 
was evaporated by rotation under nitrogen. The thin 
fdm which formed on the walls of the flask was 
dispersed in 2 ml of 5 mM potassium phosphate buffer 
(pH 7.5) containing asparaginase (150 I.U.). Aspartic 
acid (20/amol) and gelatin (2.5 mg) were added to 
stabilize the enzyme [10]. The liposomes formed by 
shaking for 2 h at room temperature were washed 
twice in saline at 100 000 g for 60 min and resuspended 
in saline. 'Empty' liposomes were prepared as above in 
the absence of asparaginase. 
2.2. Assay of asparaginase 
Enzyme assays were carried out at 37°C in 2 ml 
Tris-HC1 buffer (0.05 M, pH 8.0) containing 2/lmol 
of L-asparagine as described elsewhere [ 10]. The 
liberated ammonia was determined by direct nessleriza- 
tion and the optical density measured at 420 nm in a 
Klett-Summerson colorimeter. One unit of enzyme 
releases 1/amol of ammonia in 1 min at 37°C and 
pH 8.0. 
2.3. Heat treatment and assay of residual asparaginase 
activity 
The treatment was carried out in test tubes immersed 
in a water bath with the temperature gulated by a 
Thermomix II immersion thermostat. Samples of the 
enzyme were incubated at the desired temperature in 
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0.5 ml of Tris-HC1 buffer (0.04 M, pH 8), unless 
otherwise indicated. The treatment was terminated at 
various time intervals by immersing the test tubes in 
an ice bath for 1 min. The assay of residual activity 
was started by adding 1.5 ml of the substrate solution 
prewarmed to 37°C. 
40/amol Tris-HC1 (pH 8.0) in a total vol of 0.5 ml 
made up with normal rabbit serum. To measure 
stabilization the sample was heat-treated before the 
residual activity was determined. The procedure of 
treatment and assay was as described above. 
2.4. Trypsin treatment 
Proteolysis was carried out with trypsin (20/~g/ml) 
at 37°C in 0.5 ml of Tris-HC1 (0.04, pH 8.0). A 
freshly prepared solution of trypsin in 0.01 M CaC12 
was used in each experiment. The treatment was 
terminated by the initiation of the assay as described 
above. 
2.5. Preparation of antisera 
Antisera were prepared in rabbits by intramuscular 
injection of 20 I.U. of L-asparaginase homogenized 
with complete Freund's adjuvant. Injections were 
repeated 4 times at 10-day intervals and the rabbits 
were bled from the ear 10 days after the last injection. 
The blood was allowed to cl0t overnight and the serum 
was separated and stored at -20°C. A month after the 
last bleeding, the rabbits were given a booster injection 
of 20 I.U. of the enzyme. The sera were collected 
10 days later and stored as above. All sera were pooled 
before use. 
2.6. Neutralization and stabilization by antibody 
Samples of the enzyme were incubated for 5 rain 
at 37°C with varying amounts of antiserum and 
3. Results and discussion 
The efficiency of entrapment of L-asparaginase in 
liposomes compares favourably with that reported for 
other enzymes [7]. Thus, under the conditions 
described in Materials and methods, over 12% of the 
original enzyme activity was retained in the washed 
liposome preparation. Several runs with altered 
proportions of the lipid components resulted in 
considerably lower yields. Intact, washed liposomes 
showed about 42% of the activity of the entrapped 
enzyme, and full activity was recovered after disruption 
of the liposomes by osmotic shock. 
Entrapment of L-asparaginase in liposomes results 
in a marked increase in the thermostability of the 
enzyme. There is no increase in thermostability of the 
enzyme when added to a pre-formed enzyme-free 
liposome preparation. The thermostability is lost when 
the liposomes are suspended in distilled water and 
osmotically disrupted (table 1). 
Enclosure of L-asparaginase in liposomes imilarly 
protects the enzyme against proteolytic inactivation. 
As shown in fig. 1, incubation of free L-asparaginase 
with trypsin (20/ag/ml) leads to rapid loss of activity 
Table 1 
Thermostability of entrapped L-asparaginase 
Temperature Asparaginase activity remaining after 
heating a 
1 2 3 4 
(min) 
Intact liposomes 68°C 81.7 88.7 80.3 74.6 
70°C 82.0 66.3 55.1 55.1 
Lysed liposomes 68°C 7.3 6.3 7.3 5.2 
70°C 3.4 2.5 - 2.5 
Free enzyme 68°C 4.2 1.6 1.6 2.1 
70°C 1.1 0 0 0 
a Asparaginase activity (l.U./ml) remaining after exposure to 68°C or 70°C 
was determined as described in Materials and methods. 
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Fig.1. Resistance of entrapped L-asparaginase to proteolysis. 
The residual activity of enzyme preparations incubated at 
37°C with trypsin (20 t~g/ml) was assayed at the indicated 
time intervals. For other details ee Methods. (e) Intact 
asparaginase-liposomes; (o) lysed asparaginase-liposomes; (~x) 
asparaginase + empty liposomes; (A) asparaginase alone. 
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Fig.2. Entrapped L-asparaginase is not stabilized by antibodies 
to the free enzyme. The enzyme preparations were pre-incubat- 
ed at 37°C for 5 min with the indicated amounts of antiserum 
(see Materials and methods) and subsequently exposed to (a) 
70°C or (b) 62°C for 7 min. The residual activity was then 
determined as described in Materials and methods. For 
symbols ee fig. 1. 
of  37°C, whereas the entrapped enzyme is completely 
resistant o proteolysis under the same conditions. The 
resistance to proteolysis is lost when the l iposomes are 
disrupted by osmotic shock (fig. 1). 
These results indicated that the entrapped enzyme 
is effectively sealed within the l iposomal membranes 
and thus inaccessible to trypsin. Consistent with this 
was the further observation that the l iposome-bound 
asparaginase does not react with antibodies prepared 
against he free enzyme. It has been shown [ 11 ] that 
Table 2 
Effect of antiserum against asparaginase on the activity 
of free and entrapped enzyme 
Antiserum (~tl) 
0 0.66 1.0 2.0 
Residual activity of enzyme (I.U./ml) after incubation 
10 min at 37°C with antiserum 
0.58(0) 0.59(0) 0.59(0) 
0.41(0.17) - 0.36(0.27) 
1.12(0.18) 1.09(0.21) 1.00(0.27) 
1.15(0.08) 1.02(0.18) 0.93(0.26) 
Intact asparaginase-liposomes 0.57 
Lysed asparaginase-liposo mes 0.49 
Empty liposomes + asparaginase 1.37 
Asparaginase alone 1.25 
Figures in brackets represent fraction of activity neutralized by antibodies. 
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the antibodies neutralize to some extent he activity 
of the free enzyme. There is, however, no neutraliza- 
tion of asparaginase entrapped in intact liposomes 
(table 2). A more sensitive indicator of the interaction 
of L-asparaginase with the homologous antibodies i
provided by the observation [11 ] that the enzyme- 
antibody complex is stabilized against hermal inactiva- 
tion. The effect of increasing amounts of antibodies on 
the thermostability of L-asparaginase is shown in fig.2. 
The stabilization obtained with the free enzyme and 
with disrupted liposomes or with a mixture of the 
enzyme and 'empty' liposomes i not observed when 
the enzyme is entrapped in liposomes. It appears there- 
fore that the antigenic determinants of this enzyme 
are effectively masked by the entrapment. Conse- 
quently, intact liposomes can be considered as 
antigenically inert vehicles for this enzyme. The 
behaviour in vivo [ 12] and the therapeutic potential 
of asparaginase-liposomes is presently under evaluation. 
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